Guanfacine Tablet, Extended Release
Product Images NDC 62332-746

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Guanfacine (NDC 62332-746). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100 Tablets (Guanfacine 1 mg)

Label for Guanfacine Extended-Release Tablets, USP, 1 mg strength, oral tablet dosage form, with package size of 100 tablets. Manufactured by Alembic Pharmaceuticals Inc. The label includes storage instructions between 15° to 30°C (59° to 86°F) and cautions that tablets should not be crushed, chewed, or broken before swallowing. The label also displays the NDC number 62332-745-31 and notes that it is prescription only (Rx only).*

FDA Label Image

100 Tablets (Guanfacine 2 mg)

Label for Guanfacine Extended-Release Tablets, USP, 2 mg strength, in a package of 100 tablets. The label indicates the tablets are extended-release and should not be crushed, chewed, or broken before swallowing. It lists Alembic Pharmaceuticals Inc. as the labeler and manufacturer, with storage instructions and dosage form as oral tablets.*

FDA Label Image

Figure2 (Guanfacine 2figure)

A chart illustrating pharmacokinetic changes showing fold change and 90% confidence intervals for various substances impacting the drug's Cmax and AUC. The graph compares inhibitors and inducers such as Ketoconazole, Fluconazole, Rifampin, Efavirenz, Oral Methylphenidate, and Lisdexamfetamine Dimesylate, relative to a reference baseline.*

FDA Label Image

Figure 3 (Guanfacine 3 Figure)

A horizontal forest plot chart showing pharmacokinetic fold changes and 90% confidence intervals for the drugs Oral Methylphenidate and Lisdexamfetamine Dimesylate interacting with guanfacine. The variables include Cmax and AUC, with fold change values relative to reference ranging from 0 to 2 on the x-axis.*

FDA Label Image

100 Tablets (Guanfacine 3 mg)

Guanfacine Extended-Release Tablets, USP 3 mg, oral dosage form in tablet extended-release. The label includes storage instructions, a warning that tablets should not be crushed, chewed, or broken, and indicates the product is for prescription use only. Manufactured by Alembic Pharmaceuticals Inc., the package contains 100 tablets.*

FDA Label Image

100 Tablets (Guanfacine 4 mg)

Guanfacine Extended-Release Tablets, USP 4 mg by Alembic Pharmaceuticals Inc. The oral tablet package contains 100 tablets. The label includes storage instructions and safety warnings stating tablets should not be crushed, chewed, or broken prior to swallowing. The label includes NDC and manufacturer details, with a child-resistant package note.*

FDA Label Image

Figure1 (Guanfacine Figure 1)

A line graph comparing plasma concentration of 1 mg extended-release guanfacine tablets versus 1 mg immediate-release guanfacine over 24 hours. The vertical axis shows plasma concentration (ng/mL) and the horizontal axis shows time in hours. Extended-release guanfacine shows a gradual concentration increase and sustained level, while immediate-release peaks earlier and declines faster.*

FDA Label Image

Figure 4 (Guanfacine Figure4)

A Kaplan-Meier survival curve graph comparing treatment failure over time in days between placebo and SPD503 groups. The x-axis shows time to treatment failure from 0 to 203 days, and the y-axis shows treatment failure percentage from 0% to 100%. The placebo group has a higher failure rate over time than the SPD503 group.*

FDA Label Image

Structure (Guanfacine Str)

Chemical structure of guanfacine hydrochloride showing a chlorinated bicyclic ring attached to an acetamide group with an amino and imine functional group, representing the molecular composition of guanfacine HCl.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.